Literature DB >> 24614222

Molecular imaging biomarkers for oncology clinical trials.

David A Mankoff1, Daniel A Pryma, Amy S Clark.   

Abstract

Biomarkers can be used to characterize disease status or predict disease behavior. Cancer biomarkers have typically relied on assays of blood or tissue; however, molecular imaging has a promising and complementary role as a cancer biomarker. This "Focus on Molecular Imaging" article reviews the current role of biomarkers to direct cancer clinical trials and clinical practice, along with current and future cancer biomarker applications of molecular imaging.

Entities:  

Keywords:  cancer biomarkers; cancer therapy; clinical trials

Mesh：

Substances：

Year:  2014        PMID： 24614222     DOI： 10.2967/jnumed.113.126128

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  31 in total

Review 1.  (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.

Authors:  Tarik Z Belhocine; Francis G Blankenberg; Marina S Kartachova; Larry W Stitt; Jean-Luc Vanderheyden; Frank J P Hoebers; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-16       Impact factor: 9.236

2.  Correlation between (18)F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer.

Authors:  Hye Ryoung Koo; Jeong Seon Park; Keon Wook Kang; Wonshik Han; In Ae Park; Woo Kyung Moon
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

Review 3.  Personalized radiotherapy: concepts, biomarkers and trial design.

Authors:  A H Ree; K R Redalen
Journal:  Br J Radiol       Date:  2015-05-20       Impact factor: 3.039

Review 4.  Stem Cell Monitoring with a Direct or Indirect Labeling Method.

Authors:  Min Hwan Kim; Yong Jin Lee; Joo Hyun Kang
Journal:  Nucl Med Mol Imaging       Date:  2015-10-22

5.  Measuring temporal stability of positron emission tomography standardized uptake value bias using long-lived sources in a multicenter network.

Authors:  Darrin Byrd; Rebecca Christopfel; Grae Arabasz; Ciprian Catana; Joel Karp; Martin A Lodge; Charles Laymon; Eduardo G Moros; Mikalai Budzevich; Sadek Nehmeh; Joshua Scheuermann; John Sunderland; Jun Zhang; Paul Kinahan
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-04

6.  Tumor Targeting via Sialic Acid: [68Ga]DOTA-en-pba as a New Tool for Molecular Imaging of Cancer with PET.

Authors:  Charalambos Tsoukalas; Simonetta Geninatti-Crich; Anastasios Gaitanis; Theodoros Tsotakos; Maria Paravatou-Petsotas; Silvio Aime; Rogelio Jiménez-Juárez; Constantinos D Anagnostopoulos; Kristina Djanashvili; Penelope Bouziotis
Journal:  Mol Imaging Biol       Date:  2018-10       Impact factor: 3.488

7.  Targeted Superparamagnetic Iron Oxide Nanoparticles for In Vivo Magnetic Resonance Imaging of T-Cells in Rheumatoid Arthritis.

Authors:  Chih-Lung Chen; Tiing Yee Siow; Cheng-Hung Chou; Chen-Hsuan Lin; Ming-Huang Lin; Yung-Chu Chen; Wen-Yuan Hsieh; Shian-Jy Wang; Chen Chang
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

8.  Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.

Authors:  Kelley Salem; Manoj Kumar; Kyle C Kloepping; Ciara J Michel; Yongjun Yan; Amy M Fowler
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

Review 9.  Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers.

Authors:  Austin R Pantel; David A Mankoff
Journal:  Cancer Lett       Date:  2016-05-16       Impact factor: 8.679

Review 10.  Quantitative Imaging in Cancer Clinical Trials.

Authors:  Thomas E Yankeelov; David A Mankoff; Lawrence H Schwartz; Frank S Lieberman; John M Buatti; James M Mountz; Bradley J Erickson; Fiona M M Fennessy; Wei Huang; Jayashree Kalpathy-Cramer; Richard L Wahl; Hannah M Linden; Paul E Kinahan; Binsheng Zhao; Nola M Hylton; Robert J Gillies; Laurence Clarke; Robert Nordstrom; Daniel L Rubin
Journal:  Clin Cancer Res       Date:  2016-01-15       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.